TrialBMC cancer2018

MAP3K7 is recurrently deleted in pediatric T-lymphoblastic leukemia and affects cell proliferation independently of NF-κB.

David M Cordas Dos Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.